# Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)

> **NCT03884452** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 50 (actual)

## Conditions studied

- Familial Hypercholesterolemia

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Simvastatin
- **DRUG:** Ezetimibe
- **DRUG:** Placebo for Ezetimibe

## Key facts

- **NCT ID:** NCT03884452
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05-03
- **Primary completion:** 2001-05-24
- **Final completion:** 2001-05-24
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03884452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03884452, "Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03884452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*